Transgenic mice carrying either a 1.008 or a 4.225 kb of the mouse c-kit 5'-¯anking sequences linked to the oncogenic large T antigen (TAg) region of the simian virus 40 (SV40) genome were generated to test if the ckit promoter could be used to develop useful mouse models. Both constructs promote tumourigenesis in the pituitary and the thyroid with high eciency. The cell types from which each of these tumours derives were identi®ed. Tumours of the pituitary derive from a-MSHexpressing cells located in the intermediate lobe.
Introduction
The c-kit proto-oncogene encodes Kit, the receptor tyrosine kinase for stem cell factor (SCF). In the mouse, c-kit is allelic with the W/Kit locus. W/Kit mutations aect various aspects of hematopoiesis, as well as the proliferation and/or the survival of the germ cell and melanoblast lineages in the embryo (Lev et al., 1994) . The Kit/SCF receptor/ligand pair is also required for the postnatal development of the interstitial cells of Cajal in the small intestine (Maeda et al., 1992; Huizinga et al., 1995) . Finally, a role for the Kit/SCF pathway in the adult central nervous system has been recently demonstrated (Motro et al., 1996) . Accordingly, c-kit is expressed in each of these cells or tissues during embryogenesis. However, in situ hybridization experiments have shown that the pattern of c-kit transcription extends beyond the cells known to be aected by W mutations (Matsui et al., 1990; Orr-Urtreger et al., 1990; Keshet et al., 1991; Motro et al., 1991) .
These observations were further documented by Bernex et al. (1996) using a new allele called W lacZ .
This allele was created, using homologous recombination in embryonic stem cells, by replacing the ®rst exon of c-kit by the lacZ reporter gene in the germ line of mice. The lacZ expression in W lacZ /+ embryos faithfully recapitulates the known sites of c-kit expression and revealed unexpected sites of c-kit expression. These expression sites were documented with great accuracy and it was demonstrated that epithelial cells of the digestive tract, cells of the pituitary, the pineal organ, as well as interfollicular cells of the thyroid express c-kit (Bernex et al., 1996) . Interestingly, it is generally assumed that these cells belong to the neuroendocrine system (Launay et al., 1983) . Altogether, this analysis has identi®ed the W lacZ variants as convenient mice to follow c-kit expression.
The tissue-and temporally-speci®c transcription of c-kit in several distinct cell lineages predicts a complex organization of cis-acting elements in the c-kit gene. The nucleotide sequence analysis of the promoter of the mouse c-kit gene has been disappointing: it lacks TATA and CCAAT boxes, nor does it contain consensus binding sites for GATA-1, GATA-2 or GATA-3. This sequence includes a single potential binding site for Oct and several sites for AP-2 and SP1, while the consensus sequence GGAGG found in the promoters of several receptor tyrosine kinases is repeated ten times in the interval between 7643 and 752 bp (Yasuda et al., 1993; De Sepulveda et al., 1995) . Yasuda et al. (1993) have shown that ciselements responsible for the cell type-speci®c expression of c-kit in vitro are contained within the 105 bp of the major transcription initiation site. Yet, the 4.225 kb of c-kit 5'¯anking sequences linked to the lacZ gene failed to confer b-galactosidase (b-gal) activity to the cells that express c-kit in transgenic embryos (De Sepulveda et al., 1995) . To investigate further the ability of the c-kit promoter to drive expression of another reporter gene to a speci®c subset of c-kitexpressing cells, and to test if the c-kit promoter could be used to develop mouse models for human tumours, we generated transgenic mice by microinjection of the SV40 early region with 5'-¯anking regions of the c-kit gene into the one-cell mouse embryo. Our experiments show that the resulting transgenic mice consistently develop various neuroendocrine tumours, including intermediate lobe pituitary tumours and C cell tumours.
from the 5'¯anking region of the mouse c-kit gene were used (Figure 1 ). Kit-tT carries 4.225 kb of 5' anking sequences from the c-kit gene aligned to promote transcription of the early region of SV40. KitD-tT was derived from Kit-tT; it carries 1.008 kb of the c-kit 5'¯anking sequences as a regulatory element. The latter construct was used because the promoter activity exhibited by the 1.008 kb fragment was two to sixfold greater than the 4.225 kb fragment in transfected cells (data not shown).
Fertilized one-cell mouse embryos were microinjected with the linear DNA constructs. Thirty-three founder mice carrying one of the constructs were identi®ed by Southern blot. They were serially numbered 1 to 33. Three of them (founders 12, 19 and 31) died without descendant and were found with lysis before necropsy. Two others (founders 1 and 20), and their ospring, showed neither symptom for 2 years, nor lesion when autopsied. Thus, 28 out of 33 founder mice were informative; among them 12 and 16 carried Kit-tT and KitD-tT respectively. Several of these informative founder mice died without progeny. Finally, six and eight founder mice, carrying Kit-tT and KitD-tT respectively, gave rise to transgenic lines (Table 1) .
Southern and dot blot analyses of tail biopsies of either founder mice or their transgenic ospring revealed that most of them carried from one to approximately ten copies of Kit-tT or KitD-tT, although founder 15 carried approximately 25 copies of Kit-tT. The transgenic constructs were generally inherited autosomally. However, founder 7 was a germinal genotypic mosaic, with integration of KitDtT on the Y chromosome. Thus, from the second generation onwards, all males from line 7 were transgenic.
The presence of TAg transcripts in tissues known to express c-kit was evaluated by RT-PCR analysis on RNA from several independent transgenic mice.
Results of this analysis obtained for lines 8, 10 and 29 are shown in Table 2 . TAg transcripts were found in total RNA isolated from tissues of all tested transgenic mice, although these transcripts were not detected in all tissues known to express c-kit. Moreover, the sites of transgene transcription varied from line to line. To ascertain whether expression of TAg transcripts was directed by the c-kit 5'¯anking sequences, primer extension experiments were conducted on total RNA isolated from testis of mice from line 8 and from pituitary tumours that developed in animals from lines 7 and 8, using an oligonucleotide complementary to TAg mRNA. This analysis indicated that TAg transcripts initiated at the same nucleotide as the endogenous c-kit gene. Therefore, the expression of TAg was driven by the c-kit promoter.
Pituitary tumours in transgenic mice
Twenty-®ve out of 28 founders and/or their ospring developed pituitary tumours. These tumours appeared at a high frequency in most transgenic lines ( Table 1) . The main signs associated with pituitary tumour were equilibrium troubles, priapism in males, and frequently coat colour variation. Indeed, agouti transgenic mice often had black hairs on the tempora, the skull, the dorsal part of the neck and the shoulder region. This reduction of the phaeomelanin-associated colour was progressive, starting from the tempora and extending posteriorly. The onset of the symptoms in all transgenic mice of a given line was quite similar, but it varied from line to line. In 7 out of 14 lines, most of the mice shared evidence of illness by the age of 6 months (Table 1) . Necropsies revealed massive pituitary tumours, up to 5 mm in diameter. The tumour compressed the overlying brain and adjacent nerves. In most cases, the tumours were well de®ned and vascularized; very few tumours invaded the brain. Histopathological examination of the pituitary of Figure 1 Representation of the Kit-TAg constructs. Kit-tT (a) and KitD-tT (b) carry the SV40 early region (thick solid line) fused to sequences derived from the 5'¯anking region of the mouse c-kit gene (boxed region). The L-shaped arrow depicts the c-kit gene major transcription start site (Yasuda et al., 1993) . The translation initiation sites of c-kit and TAg are marked by boxed ATGs. The polyadenylation site of the SV40 early region is indicated by a boxed An. This fragment of the SV40 early region includes the coding region for the small and large tumour antigens yet lacks all known components of the SV40 early promoter animals which looked healthy at the time of sacri®ce revealed adenoma of the pars intermedia (Figure 2a) . The pars distalis and the pars nervosa were not neoplastic, but they were frequently compressed by the adjacent tumour and atrophic.
To further characterize the transformed cells, sections of pituitary tumours from transgenic heterozygous mice were analysed using several antibodies. Anti-TAg antibody stained scattered cells or multifocal nodules in small tumours. In large tumours, almost all transformed cells were TAg-positive (Figure 3a,b) . amelanocyte stimulating hormone (a-MSH) is an intermediate lobe-speci®c cleavage product of the prohormone pro-opiomelanocortin (Roberts et al., 1980) . a-MSH was detected in most tumours ( Figure  2b ), although the staining was lower than in normal pars intermedia. This a-MSH expression likely accounts for the coat color phenotype of the transgenic mice (Geschwind and Huseby, 1966) . Chromogranin A (CgA) is a secretory granule matrix glycoprotein used to identify neuroendocrine differentiation in neoplasia (Wilson and Lloyd, 1984; Deftos, 1991) . Pituitary tumours showed areas of atypic cells weakly positive for CgA. Neuron-speci®c enolase (NSE) is a cytosolic protein found to occur in all types of normal neuroendocrine cells (Bishop et al., 1982; Schmechel et al., 1978) , and their neoplasms (Tapia et al., 1981) . Pituitary tumours showed areas of proliferative cells either weakly or strongly positive for NSE. We took advantage of the W lacZ allele to search for c-kit expression post-natally in the pituitary. In the normal pituitary of 7 week-and 6 month-old W lacZ /+ mice, more than 80% of the cells of the pars intermedia and few cells of the pars distalis displayed high b-gal activity, while no cells were stained in the pars nervosa ( Figure 2c ). W lacZ /+ females were mated to KitD-tT/+ males (line 9) and double-transgenic mice were produced. In the pituitary tumours of doubletransgenic mice, the number of lacZ-expressing cells dropped as the number of cells with reduced cytoplasm and darkly stained nuclei increased ( Figure 2d ). From these studies we conclude that: (1) pituitary tumours in Kit-tT and KitD-tT mice were derived from melanotroph cells of the pars intermedia; (2) they often still expressed neuroendocrine markers, such as CgA, NSE, and a-MSH; (3) they lost their ability to express endogenous c-kit gene as they acquired a transformed phenotype.
Thyroid tumours
Thyroid tumours appeared in 8 out of 28 founders and/or their ospring (Table 1 ). The penetrance of the phenotype was highly variable: almost all mice from line 26, but only half from line 9, and few individuals from lines 8 and 24 developed thyroid tumours. These tumours were associated with several symptoms: from dyspnea to serious breathing diculties, frequent squeaks due to compression of the trachea, emaciation, and pain as indicated by bowed thoracic vertebra. In most lines, the symptoms were detected by 3 ± 5 months of age. The autopsies revealed either unilateral or bilateral thyroid tumours which generally consisted of well de®ned, white and moderately ®rm nodules. Histological examination revealed features of focal epithelial hyperplasia, adenoma or carcinoma. By 3 months of age, foci of cells with an increased nuclear/ cytoplasmic ratio and a high proliferative activity appeared and progressively obliterated the follicles (Figure 4a ). Signs of malignancy, including thyroid capsule disruption and invasion of the tracheal submucosa and adjacent muscles, were occasionally observed. In line 21, rare cases of deep cervical lymph node hyperplasia evoked metastasis. We looked for expression of calcitonin in normal and tumourous thyroids. In normal thyroid, calcitoninexpressing cells are scattered over the gland, located in the interstitial tissue between the follicles or between the thyrocytes. In small tumours, calcitonin-positive cells were numerous in the epithelium replacing follicular cells (Figure 4b ). As the tumours developed, a signi®cant increase of calcitonin-positive cell number was observed, raising the diameter of the follicles and reducing the size of the colloid. These calcitoninexpressing tumours also showed areas of cells positive for CgA and NSE. Immunohistochemical staining revealed that almost all transformed cells of both adenoma and carcinoma expressed TAg ( Figure 5) .
We analysed the lacZ expression pattern in the thyroid from W lacZ /+ adult mice. Cells, identi®ed as mast cells, endothelial cells and parafollicular cells, expressed the lacZ gene in the normal adult thyroid. The same pattern was observed in W lacZ /+ embryos from 14.5 onwards (Bernex et al., 1996) . Surprisingly, double-staining using X-Gal and anti-calcitonin antibody showed that the b-gal-positive parafollicular cells expressed no detectable calcitonin. A possibility is that these Kit-positive cells found in parafollicular location within the thyroid gland of both embryos and adults are C cell precursors. We have also analysed the lacZ expression pattern in transformed foci of the thyroid from double transgenic W lacZ /+ KitD-tT/+ mice. No b-gal-positive cells were seen in the centre of the tumours, although few scattered b-gal-positive cells were occasionally found at their periphery.
Altogether, these data led us to conclude that: (1) thyroid tumours resulted from the proliferation of C cells under the in¯uence of TAg; (2) they likely derived from the transformation of either dierentiated C cells or C cell precursors, associated with the loss of c-kit expression during tumoural progression.
Tumours occurring in a small number of independent lines
In addition to the pituitary and thyroid tumours, eleven neoplastic lesions were observed in Kit-tT and KitD-tT mice. Furthermore, mice from lines 8, 29 and 30 developed hyperplasia and dysplasia of ganglion cell layer and nuclear layer of the retina. All lesions were 
, identical lesions were reproducibly observed in transgenic mice within a given line (Table 3) , thus indicating that they represented heritable phenotypes resulting from the transgene integration. Indeed, all tumours were TAg-positive. The incidence of macroscopic lesions varied from line to line, but it could reach 100% as for Harderian gland and ocular lens tumours (Table 3) . We searched for CgA expression in all these hereditary tumour types. Six out of ten were CgA positive (Table 3) . Furthermore pinealomas and carcinoid tumours of the stomach were labelled with the anti-NSE antibody, immunoreactivity being present in numerous transformed cells in each case (Figure  6b,d) .
We looked for lacZ expression in the normal corresponding tissues from W lacZ /+ adults. b-galpositive cells were found in epithelial cells of the ampullary glands, in the exocrine pancreas, in the ganglion cell layer and the nuclear layer of the retina, in the brown fat tissue, in the pineal organ, in scattered cells of the pyloric glands and the muscularis of the stomach, in parafollicular cells of the Harderian glands and in the interstitial tissue of the testis (data not shown). No b-gal-activity could be detected in the adrenal gland and in the lens, nor were the macrophages, from which histiocytomas are derived, stained. However, b-gal-positive cells were found in the lens of W lacZ /+ embryos from E14.5 onwards (Bernex et al., 1996) , while hematopoietic GM-CFC precursors express Kit (Ogawa et al., 1993) . Altogether, these tumours likely derived from cells that express c-kit either in the embryo and/or in the adults. Tumours of the adrenal cortex gave the only exception; they could result from the in¯uence of regulatory elements contained in the genomic region¯anking the transgene, rather than from the c-kit regulatory sequences, since these tumours were found in a single transgenic line (Table 3) .
Discussion
The neuroendocrine system includes the neurosecretory cells of the central and peripheral nervous system and the diuse endocrine system. It predominantly acts at a local level, by way of paracrine secretion of polypeptide hormones. Nevertheless, some of these chemical messengers may also act as classical hormones. Among the cells that belong to the neuroendocrine system, several have been studied intensively, as the hypothalamic-hypophyseal and the gastro-entero-pancreatic systems (Gepts and Rahier, 1984) . Out of the twelve hereditary tumours found in Kit-TAg mice, four are classically referred to as neuroendocrine tumours: melanotroph cell tumours, C cell tumours, carcinoid tumours of the stomach and pinealomas (Launay et al., 1983) . Accordingly, all these tumours expressed CgA and/or NSE, general neuroendocrine cell markers 13% (15) 80% (31) 14% (7) 23% (13) 48% (31) 28% (7) 25% (31) 100% (7) 100% (14) 66% (3) 60% ( (Bishop et al., 1988; KloÈ ppel and Heitz, 1994) . Moreover, melanotroph and C cell tumours expressed speci®c hormonal peptides, a-MSH and calcitonin respectively. Five additional tumours showed CgA staining (see Table 3 ). The appearance of tumours in neuroendocrine tissues of Kit-TAg mice may be explained since c-kit is expressed in various neuroendocrine cells. Indeed, the study of the lacZ reporter gene expression in W lacZ /+ embryos (Bernex et al., 1996) and adults (our results), revealed that c-kit is expressed in cells in the pars intermedia of the pituitary, in parafollicular cells in the thyroid, in cells from the pineal organ and in the pyloric glands of the stomach. These observations are compatible with the idea that these neuroendocrine tumours resulted from the direct control of the TAg expression by the c-kit 5'¯anking region.
The high incidence of tumours originating from the intermediate lobe pituitary and from the thyroid of the transgenic mice may be explained by the mechanism of action of SV40 TAg. Indeed, it is admitted that TAg is active in particular through its ability to bind and sequester the retinoblastoma susceptibility gene (Rb) product (for review see Van Dyke, 1994) . Mice heterozygous for targeted disruption in the Rb gene are highly susceptible to tumours originating from the intermediate lobe of the pituitary and to C cell carcinoma (Hu et al., 1994; Williams et al., 1994; Harrison et al., 1995) . It has been recently demonstrated that inactivation of the wild-type Rb allele in the Rb +/7 mice is associated with continuous proliferation of melanotrophs in the pituitary (Nikitin et al., 1996) , thus showing that Rb is an important negative regulator for the proliferation of melanotrophs, and also possibly for C cells. In the Kit-TAg transgenic mice sequestration of Rb by TAg would lead to a more pronounced tumour susceptibility in those tissues where the absence of Rb causes a neoplastic lesion with the higher eciency.
Our results indicate that 1.008 kb of the mouse c-kit 5'¯anking sequences direct TAg expression to melanotroph cells of the pituitary. Transgenic mice carrying 706 bp of the rat pro-opiomelanocortin (POMC) promoter fused to the SV40 early region develop pituitary tumours arising from the intermediate lobe. Both the time course of tumour progression and the histological characteristics were identical to those described in this report (Low et al., 1993) . Interestingly, a transgene containing 706 pb POMC promoter fused to the lacZ gene started to be expressed during embryogenesis at E15.5 in the presumptive intermediate lobe of the pituitary, thus re¯ecting with a 1-day delay the POMC endogenous gene expression (Liu et al., 1992) . Similarly, the c-kit endogenous gene expression is detected from E15.5 onwards in the intermediate pars of the pituitary (Bernex et al., 1996) . This identity in melanotroph-speci®city and in the temporal-speci®city of the POMC and c-kit endogenous genes expression, as well as the identity in the eects induced by the use of their 5'¯anking sequences driving the SV40 early region, suggests that both genes share a common regulatory element, presumably in the 1.008 kb and 706 pb located immediately upstream from the 5' end of the c-kit and POMC genes respectively. The sequences responsible for the corticotroph-speci®city of the POMC gene have been extensively characterized (Therrien and Drouin, 1993; Lamonerie et al., 1996) . By contrast, little data is available on elements conferring cell-speci®city of POMC transcription in melanotrophs, as there are no representative cell lines. The pituitary tumours of KitTAg mice oer the opportunity to derive such cell lines. Indeed, the immortalizing properties of TAg have been successfully used to isolate various cell lines from transgenic mice harboring certain tissue-speci®c promoters fused to the SV40 early region (Sigmund et al., 1990; Antoine et al., 1992; Wikenheiser et al., 1993; Vicart et al., 1994) . Of course, this strategy could be extended to the other neuroendocrine cell types giving rise to tumours in Kit-TAg mice.
The role of the Kit/SCF pathway has been investigated in a variety of tumours in humans. In accordance with the oncogenic potential of c-kit, two mechanisms have been found that are associated with the constitutive activation of this pathway in transformed cells: (1) mutations in c-kit that are associated with ligand-independent phosphorylation of Kit (Kitayama et al., 1995; Nagata et al., 1995; Longley et al., 1996) ; (2) co-expression of both Kit and SCF in given cells that may result in autocrine growth stimulation (Hibi et al., 1991; Turner et al., 1992; Cohen et al., 1994; Hines et al., 1995) . Other neoplastic transformations have been shown to be correlated with extinction of c-kit expression. Indeed, while breast epithelium expresses high level of Kit, its malignant transformation is associated with a signi®cant decrease of Kit expression (Natali et al., 1992) . Similar losses of c-kit expression are also observed in cultured melanoma cells, in cutaneous melanoma and in thyroid carcinoma (Lassam and Bickford, 1992; Natali et al., 1992 Natali et al., , 1995 . We show here that transformation of melanotrophs is associated with loss of c-kit expression in Kit-TAg mice. If c-kit controls the dierentiation of melanotrophs in the normal pituitary, its lack of expression in transformed melanotrophs might indicate an acquired independence of tumourous cells on the Kit/SCF pathway. Alternatively, its loss of expression might re¯ect the dierentiation stage of the transformed cells with no functional relevance.
Altogether, this study suggests a previously unsuspected tissue-speci®city of the c-kit 5'-¯anking sequences for various neuroendocrine cells. Finally, the Kit-TAg transgenic animals should be useful in de®ning the early stages of neuroendocrine tumourigenesis and to follow their progression to the malignant stage.
Materials and methods

Plasmids
To construct Kit-tT, the 2.6 kb AvrII/BamHI fragment of SV40 DNA was introduced at position +76 relative to the transcription start point in a 4301 bp fragment of the c-kit promoter (De Sepulveda et al., 1995) after appropriate modi®cations of the restriction sites. Kit-tT carries nucleotides 74225 to +76 from c-kit gene linked to nucleotides 2533 to 5187 from SV40 DNA (Kryszke and Yaniv, 1990) . Our strategy for the construction of Kit-tT led to create a stop codon 27 bp upstream from the ATG initiation codon of the SV40 T gene. Thus we preliminary proved that TAg is expressed following transfection with Kit-tT in 3T3NIH ®broblasts and in melan-a melanocytes. The melan-a line was established by Bennett et al. (1987) . KitD-tT was obtained by removing a SalI/BglII inner fragment from Kit-tT; it carries the 5'¯anking region of ckit spanning nucleotides 71008 to +76 linked to the SV40 early region.
Microinjection and DNA analysis
The hybrid genes were microinjected into fertilized (C57BL/66CBA/J)F2 eggs as described (Hogan et al., 1994) . The transgenic lines were maintained for at least two generations by breeding transgenic males with normal (C57BL/66CBA/J)F1 females. These lines are designated Tg(0 Kit-tT or KitD-tT)GMn, n refers to the serial number (Lyon, 1989 ). They will be therein referred by the serial number.
Transgenic mice were identi®ed by PCR analysis on genomic DNA prepared from tails of recently weaned mice. The following oligonucleotide primer speci®c for the early region of the TAg gene: 5'-CAGGCTGTTGATACTGTTT-TAGC-3' and 5'-CATAATTCAAGCAAA-3' were used. The thermocycling protocol was as follows: an initial denaturation step at 948C for 5 min, followed by 30 cycles of 948C for 1 min, 598C for 1.5 min, and 728C for 2 min. Identi®cation of transgenic mice was con®rmed by Southern analysis using a 3 kb BamHI fragment from the Kit-tT construct as a probe.
Analysis of RNA
Total RNA was extracted as described by Chomczynski and Sacchi (1987) and analysed by RT-PCR and primer extension experiments. For RT-PCR, TAg transcripts were reverse-transcribed from a 20-mer primer (5'-TTTGCAGC-TAATGGACCTTC-3') with AMV reverse transcriptase. cDNA products were ampli®ed by PCR using the following primers: 5'-GGGGAATATTCCTCTGATGAG-3' and 5'-TTCTTGTATAGCAGTGCAGC-3'. Ampli®cations were made by a round of 35 cycles of 948C for 1 min, 548C for 1 min, and 728C for 1 min. The ampli®ed cDNA were analysed on a 1.6% agarose gel.
Primer extension experiments were done with a 32 P-endlabeled 31-mer oligonucleotide (Teitz et al., 1993 ) hybridized in conditions previously described (Panthier et al., 1984) . After hybridization, samples were reacted with AMV reverse transcriptase. This treatment was followed by phenol extraction, ethanol precipitation and electrophoresis onto a 6% sequencing gel.
Histopathology and immunocytochemistry
For histopathology, fresh tissues were ®xed in 10% phosphate-buered formalin and embedded in paran. Sections 5 mm thick were stained with haematoxylin and eosin. To localize endocrine peptides, both indirect immuno¯uorescence and avidin-biotin peroxydase techniques were performed onto formalin ®xed paran sections using anti-a-MSH rabbit polyclonal antibody (Aniti, U.K.), anti-calcitonin rabbit polyclonal antibody (Monosan, Netherlands), anti-CgA sheep polyclonal antibody (Aniti, U.K.) and anti-NSE rabbit polyclonal antibody (Anity, U.K.). The incubation with the primary antibodies was carried out for 16 h at 48C. The omission of the ®rst antibodies was included to demonstrate the immunostaining speci®city. To localize TAg, fresh tissues were embedded in OCT medium (Miles Scienti®c) and snapfrozen in liquid nitrogen. Frozen sections 7 to 10 mm thick were ®xed in 2% paraformaldehyde (PFA) in phosphatebuered saline (PBS) for 10 min. After permeabilization in 0.25% NP40 in PBS for 10 min, anti-SV40 TAg rabbit polyclonal antibody (provided by D Hanahan) were applied for 16 h at 48C. Then, indirect immunofluorescence was performed.
For b-gal activity detection, the fresh tissues were ®xed in 4% PFA in PBS for 60 min at 48C, rinsed twice in PBS and treated in 30% sucrose in PBS for 16 h at 48C. Then the samples were snap-frozen in OCT medium and cryostatsectioned. Afterwards the sections were post-®xed in acetone for 10 min, and stained in X-Gal buer (0.4 mg/ml 5-bromo-4-chloro-3-indolyl-D-galactoside, 2 mM potassium ferricyanide, 2 mM potassium ferrocyanide and 4 mM MgCl2 in PBS) for 16 h at 328C. Counterstaining was done either with neutral red or haematoxylin and eosin.
